| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |